Paper36969241
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.
Bonilla H and 24 others. Front Immunol, 2023. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Papers, record 36969241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969241
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Virus Diseases | Major topic |
| United States | |
| Humans | |
| SARS-CoV-2 | |
| Post-Acute COVID-19 Syndrome | |
| Motivation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 AI157875 | NIAID NIH HHS | United States | K23AI157875 | PubMed and NIH | NIH RePORTER |
| L30 AI147159 | NIAID NIH HHS | United States | L30AI147159 | PubMed and NIH | NIH RePORTER |
| OT2 HL161847 | NHLBI NIH HHS | United States | OT2HL161847 | PubMed and NIH | NIH RePORTER |
| UM1 TR004528 | NCATS NIH HHS | United States | UM1TR004528 | PubMed | NIH RePORTER |
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20632887 | Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. | J Infect Dis | 2010 | https://conductscience.org/library/papers/20632887 | PubMed |
| 2 | 32953984 | CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease. | Mol Ther Oncolytics | 2020 | https://conductscience.org/library/papers/32953984 | PubMed |
| 3 | 33631065 | Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33631065 | PubMed |
| 4 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 5 | 35215212 | Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. | Pathogens | 2022 | https://conductscience.org/library/papers/35215212 | PubMed |
| 6 | 34921756 | Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. | Lancet | 2022 | https://conductscience.org/library/papers/34921756 | PubMed |
| 7 | 34677601 | Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | J Infect Dis | 2021 | https://conductscience.org/library/papers/34677601 | PubMed |
| 8 | 36113467 | Epstein-Barr virus: Biology and clinical disease. | Cell | 2022 | https://conductscience.org/library/papers/36113467 | PubMed |
| 9 | 35709281 | Clues to long COVID. | Science | 2022 | https://conductscience.org/library/papers/35709281 | PubMed |
| 10 | 36337437 | High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. | Lancet Reg Health Eur | 2023 | https://conductscience.org/library/papers/36337437 | PubMed |
| 11 | 26965674 | HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. | Nat Rev Neurol | 2016 | https://conductscience.org/library/papers/26965674 | PubMed |
| 12 | 35226158 | Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. | Eur Radiol | 2022 | https://conductscience.org/library/papers/35226158 | PubMed |
| 13 | 28603794 | Post-Exertional Malaise in Patients with ME and CFS with Comorbid Fibromyalgia. | SRL Neurol Neurosurg | 2017 | https://conductscience.org/library/papers/28603794 | PubMed |
| 14 | 36517603 | SARS-CoV-2 infection and persistence in the human body and brain at autopsy. | Nature | 2022 | https://conductscience.org/library/papers/36517603 | PubMed |
| 15 | 34445329 | Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445329 | PubMed |
| 16 | 34425843 | Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. | Cardiovasc Diabetol | 2021 | https://conductscience.org/library/papers/34425843 | PubMed |
| 17 | 35240997 | Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/35240997 | PubMed |
| 18 | 33536023 | Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole. | J Transl Med | 2021 | https://conductscience.org/library/papers/33536023 | PubMed |
| 19 | 35082169 | Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. | Gut | 2022 | https://conductscience.org/library/papers/35082169 | PubMed |
| 20 | 35768006 | Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. | Cell | 2022 | https://conductscience.org/library/papers/35768006 | PubMed |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964321 | Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany: the PreVitaCOV randomised clinical trial. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/42964321 | PubMed |
| 42521821 | Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial. | Nat Med | 2026 | https://conductscience.org/library/papers/42521821 | PubMed |
| 42313767 | Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative. | PLoS One | 2026 | https://conductscience.org/library/papers/42313767 | PubMed |
| 42163969 | The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/42163969 | PubMed |
| 42075130 | Multi-Strain Probiotic Intervention Modestly Modulates Microbial Composition and Inflammatory Profile in Individuals with Long COVID. | Microorganisms | 2026 | https://conductscience.org/library/papers/42075130 | PubMed |
| 42056279 | Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42056279 | PubMed |
| 41993482 | Intranasal Anti-CD3 Antibody Treatment Attenuates Post-COVID Neuroinflammation and Enhances Hippocampal Neurogenesis and Cognitive Function in Mice. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993482 | PubMed |
| 41975034 | Understanding the long-term neurological effects of SARS-CoV-2 infection. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/41975034 | PubMed |
| 41969525 | Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and in silico therapeutic targeting. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/41969525 | PubMed |
| 41917225 | Long COVID disability burden in US adults. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/41917225 | PubMed |
| 41875425 | Differential Factors Associated With the Presence of Persistent Symptoms in Individuals Diagnosed With Long COVID: Protocol for a Longitudinal Matched Case-Control Study. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/41875425 | PubMed |
| 41642863 | Children and adolescents: Respiratory infection and long-term effects longitudinal study (CARE Study): Study protocol. | PLoS One | 2026 | https://conductscience.org/library/papers/41642863 | PubMed |
| 41598473 | Impact of Pulmonary Rehabilitation on Physical, Mental Health and Quality of Life in Children with Post-COVID-19 Condition: A 12-Month Quasi-Experimental Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41598473 | PubMed |
| 41438970 | Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/41438970 | PubMed |
| 41387017 | Patient perspectives on the usability and content validity of the assessment of burden of chronic conditions tool for post-COVID in the Netherlands: a qualitative study. | BMJ Open | 2025 | https://conductscience.org/library/papers/41387017 | PubMed |
| 41330562 | Persistent sleep symptoms in post-COVID syndrome: a Brazilian prospective clinical study. | Arq Neuropsiquiatr | 2025 | https://conductscience.org/library/papers/41330562 | PubMed |
| 41318861 | Lingering echoes of SARS-CoV-2: mechanistic insights and management of long COVID syndrome. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41318861 | PubMed |
| 41235241 | Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair. | Front Immunol | 2025 | https://conductscience.org/library/papers/41235241 | PubMed |
| 41158347 | The post-COVID-19 pulmonary sequelae: manifestations, mechanisms and treatment strategies. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/41158347 | PubMed |
| 41157147 | The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome. | Molecules | 2025 | https://conductscience.org/library/papers/41157147 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969241
GET https://conductscience.org/api/papers/v1/36969241/authors?page=2